CFG Capital Markets, the investment banking platform of Capital Funding Group, announced it was an advisor on a $141.7 million portfolio.
Bulk TV & Internet has become an authorized partner of Mitel, a provider of cloud and premises-based unified communications and collaboration software.
Oak Grove Capital announced it has closed a $259 Fannie Mae DUS credit facility for Brookdale Senior Living.
Dakim BrainFitness has won a silver Edison Award. The awards recognize innovation.
GOJO Industries has announced the launch of SMARTLINK™ Hand Hygiene solutions to increase hand hygiene compliance.
A new Amazon Kindle 4 case is geared toward those with arthritis or carpal tunnel syndrome. The Wingo case has wings on each side, allowing the user to comfortably rest his or her hands while using the device.
Crest Healthcare Supply has introduced a bed control holder that is easily attachable to headboards and rails.
McKnight's has launched its second annual McKnight's Excellence in Technology Awards. The awards are open at no cost to skilled nursing and assisted living facilities, and continuing care retirement communities.
Relias Learning, the parent company of Silverchair Learning Systems, announced Monday it had acquired Care2Learn from VectorLearning.
A new technology eliminates urine odor when added to absorbent undergarment fabrics, a firm has announced.
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury's previous verdict. The jury determined Pfizer marketed Neurontin for bipolar disorder, migraines and neuropathic pain. The Food and Drug Administration had not approved the medicine for any of those uses.
The approval of Biogen Idec's MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne Interactive, 40% of U.S neurologists polled said they're currently warehousing patients in anticipation of the new multiple sclerosis drug.
The estate of a woman who died in an Emeritus Corp. senior living community may pursue wrongful death and medical malpractice claims without providing expert testimony, U.S. District Court Judge Dan Aaron Polster has ruled.
